Hepatitis A and E: update on prevention and epidemiology

Vaccine
David FitzSimonsPierre Van Damme

Abstract

In March 2009 the Viral Hepatitis Prevention Board (VHPB) organized a meeting in Antwerp, in order to review the status of epidemiology and prevention of both hepatitis A and E. International hepatitis experts from the public health and academic sector provided the state of the art on HAV and emphasized the growing public health importance of the disease, in particular in intermediate endemicity regions, and the need for control at global level. The information shared on HEV showed clearly that it is emerging, but still a lot of efforts are needed to clarify among others the transmission routes, the clinical presentations and the burden of disease. First data on hepatitis E vaccines were discussed, showing a promising safety and efficacy profile. The meeting was concluded with lessons learnt, challenges, needs and proposed step forwards for both diseases.

References

Mar 3, 2007·The New England Journal of Medicine·Mrigendra Prasad ShresthaBruce L Innis

❮ Previous
Next ❯

Citations

Dec 18, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Laura A YanezViviana E Ré
Jan 1, 2010·Mediterranean Journal of Hematology and Infectious Diseases·Sanaa M KamalRunia El-Fouly
Oct 20, 2011·International Journal of Health Geographics·Khayriyyah Mohd HanafiahSteven T Wiersma
Feb 16, 2013·Food and Environmental Virology·David H Kingsley
Jan 30, 2013·Wiener klinische Wochenschrift·Zuzana BlechováVilma Marešová
Oct 12, 2012·Intervirology·Joseph C ForbiSimon M Agwale
Aug 22, 2012·Current Opinion in Infectious Diseases·Greet HendrickxPierre Van Damme
Sep 2, 2011·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Irene CacciolaGiovanni Raimondo
Aug 21, 2010·Vaccine·Kathryn H Jacobsen, Steven T Wiersma
Jan 2, 2010·Vaccine·Subhash C Arya, Nirmala Agarwal
Mar 18, 2011·Journal of Medical Virology·Luciane Almeida AmadoAna Maria Coimbra Gaspar
Oct 25, 2011·Journal of Medical Primatology·Apiradee TheamboonlersYong Poovorawan
Apr 25, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Jun YanOsamu Yokosuka
Jun 1, 2013·Medicinal Research Reviews·Yannick DebingHendrik Jan Thibaut
Feb 8, 2014·Human Vaccines & Immunotherapeutics·Zhi-lun ZhangWei-ming Fu
Jan 8, 2013·Human Vaccines & Immunotherapeutics·Eduardo Lazcano-PonceEduardo Ortega-Barria
Jan 8, 2014·Obstetrics & Gynecology Science·Geum Joon ChoHai Joong Kim
Apr 14, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Katharina Esser-NobisVolker Lohmann
Dec 8, 2016·Human Vaccines & Immunotherapeutics·Ignasi ParrónUNKNOWN Working Group for the Study of Hepatitis A in Catalonia
Jul 3, 2015·International Journal of Environmental Research and Public Health·Renata Santos TourinhoVanessa Salete de Paula
Jun 1, 2011·Osong Public Health and Research Perspectives·Haesun YunYoungmee Jee
Mar 1, 2012·Osong Public Health and Research Perspectives·Haesun YunMi Kyung Kim
Apr 11, 2012·World Journal of Hepatology·Elisabetta FrancoLaura Zaratti
Mar 17, 2018·BioMed Research International·Juliana Gil MelgaçoMarcelo Alves Pinto
Aug 1, 2012·Emerging Microbes & Infections·Dianjun Cao, Xiang-Jin Meng
Feb 8, 2019·Scientific Reports·Chikako YamamotoJunko Tanaka
Jul 12, 2019·Scandinavian Journal of Public Health·Paul R HunterJan C Semenza
Aug 29, 2021·Pharmaceutics·Dong-Hwi KimIn-Soo Choi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.